Scientists ready to resume cloning studies

May 8, 2006

At least two U.S. research teams are reportedly planning to resume efforts to clone human embryos despite opposition from the federal government.

University of California-San Francisco scientists announced Friday the resumption of a program to create new stem-cell lines that can be used to model genetic diseases.

In addition, a California company -- Advanced Cell Technology Inc. -- says it plans to recruit female egg donors and is interested in creating tailored transplant treatments, The Wall Street Journal reported Monday.

The cloning of embryos is controversial, but advocates say cloning may provide a method to make customized stem cells useful in medical research.

Additionally, some universities are also considering starting or resuming such research, the Journal said.

Although President George W. Bush has outlawed the use of all but a limited number of stem-cell lines, several states have enacted laws encouraging and regulating such research. Californians have voted to provide up to $3 billion in stem-cell research funding during the next decade.

Copyright 2006 by United Press International


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 3.8 /5 (4 votes)


May 8, 2006 all stories

Comments: 0

3.8 /5 (4 votes)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories

  • Small mechanical forces have big impact on embryonic stem cells
    created Oct 18, 2009 | popularity not rated yet | comments 0
  • SKorean cloning expert to re-create dogs for province
    created Aug 31, 2009 | popularity not rated yet | comments 0
  • Predicting cancer prognosis
    created Aug 27, 2009 | popularity not rated yet | comments 0
  • Stem cell research: From molecular physiology to therapeutic applications
    created Jul 29, 2009 | popularity not rated yet | comments 0
  • Researchers create first targeted knockout rats using zinc finger nuclease technology
    created Jul 23, 2009 | popularity not rated yet | comments 0


Other News

People entering their 60s may have more disabilities today than in prior generations

Medicine & Health / Health

created 6 hours ago | popularity 4 / 5 (2) | comments 0

(PhysOrg.com) -- In a development that could have significant ramifications for the nation's health care system, Baby Boomers may well be entering their 60s suffering far more disabilities than their counterparts did in previous ...


A child sleeping (Sleep)

Dreams may have an important physiological function

Medicine & Health / Neuroscience

created 14 hours ago | popularity 3.6 / 5 (14) | comments 7

(PhysOrg.com) -- Dreams have long been assumed to have psychological functions such as consolidating emotional memories and processing experiences or problems, but according to a Harvard psychiatrist and sleep ...


Dopamine enhances expectation of pleasure in humans

Dopamine enhances expectation of pleasure in humans

Medicine & Health / Neuroscience

created 11 hours ago | popularity 3.9 / 5 (7) | comments 0

(PhysOrg.com) -- Enhancing the effects of the brain chemical dopamine influences how people make life choices by affecting expectations of pleasure, according to new research from the UCL Institute of Neurology.


Gene knockout may cheer up mice

Medicine & Health / Neuroscience

created 4 hours ago | popularity 5 / 5 (1) | comments 0

Removing the PKCI/HINT1 gene from mice has an anti-depressant-like and anxiolytic-like effect. Researchers writing in the open access journal BMC Neuroscience applied a battery of behavioral tests to the PKCI/HINT1 knocko ...


Quarter of a million children in England at risk of skin cancer from sunbeds

Medicine & Health / Health

created 4 hours ago | popularity not rated yet | comments 0

An estimated quarter of a million 11-17 year olds in England are being put at increased risk of developing malignant melanoma by using sunbeds, warn researchers in a letter to this week's BMJ.